Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation

First Wave BioPharma, Inc. (AZRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Sold 1,676 shares @ $0.29, valued at $486
10/06/2023 4 SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Sold 2,764 shares @ $0.29, valued at $801.6
07/05/2023 4 Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Sold 1,977 shares @ $1.54, valued at $3k
07/05/2023 4 SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Sold 3,349 shares @ $1.54, valued at $5.2k
04/05/2023 4 Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Sold 1,975 shares @ $2.5, valued at $4.9k
04/05/2023 4 SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Sold 3,347 shares @ $2.5, valued at $8.4k
01/05/2023 4 Coelho Mary Theresa (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 84,745 shares @ $0
01/05/2023 4 Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 150,000 shares @ $0
01/05/2023 4 SAPIRSTEIN JAMES (President and CEO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 300,000 shares @ $0
01/05/2023 4 BORKOWSKI EDWARD (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 84,745 shares @ $0
01/05/2023 4 Hoffman David Andrew (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 84,745 shares @ $0
01/05/2023 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 84,745 shares @ $0
01/05/2023 4 Riddell Alastair (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 84,745 shares @ $0
03/02/2022 4 Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 150,000 options to buy @ $1.18, valued at $177k
01/03/2022 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 34,482 options to buy @ $1.45, valued at $50k
01/03/2022 4 Riddell Alastair (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 34,482 options to buy @ $1.45, valued at $50k
01/03/2022 4 Coelho Mary Theresa (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 34,482 options to buy @ $1.45, valued at $50k
01/03/2022 4 BORKOWSKI EDWARD (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 34,482 options to buy @ $1.45, valued at $50k
01/03/2022 4 SAPIRSTEIN JAMES (PRES, CEO & CHAIRMAN OF BOARD) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 150,000 options to buy @ $1.45, valued at $217.5k
01/03/2022 4 Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 7,500 options to buy @ $1.45, valued at $10.9k
01/03/2022 4 Oakes Gregory (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 34,482 options to buy @ $1.45, valued at $50k
01/03/2022 4 Schneiderman Daniel H (CFO) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 10,000 options to buy @ $1.45, valued at $14.5k
01/03/2022 4 Schramm Vern Lee (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 34,482 options to buy @ $1.45, valued at $50k
09/13/2021 4 Coelho Mary Theresa (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 10,310 options to buy @ $0.64, valued at $6.6k
07/09/2021 4 Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 100,000 options to buy @ $0.75, valued at $75k
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 4 Oakes Gregory (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 41,237 options to buy @ $0.97, valued at $40k
01/06/2021 4 Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 41,237 options to buy @ $0.97, valued at $40k
01/06/2021 4 Riddell Alastair (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 41,237 options to buy @ $0.97, valued at $40k
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy